latest thinking on treating osteoporosis in postmenopausal women
Here's the latest thinking on treating osteoporosis in postmenopausal women.
Fosamax and Actonel are widely-used oral bisphosphonates. They increase bone density and prevent fractures by inhibiting bone resorption. But some patients can't take them due to GI side effects.
Zometa (zoledronic acid) is also a bisphosphonate, but it's given IV. It's recently approved for hypercalcemia and bone metastases in cancer patients.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote